History
vivostat® idea to system
History
2021
two market introductions
Obsidian® ASG and Obsidian® RFT
In 2021, we brought two autologous, platelet enriched bioactive matrixes to the market. Obsidian® ASG for anastomotic reinforcement and protection following resection surgery in the gastrointestinal tract and Obsidian® RFT for regenerative treatment of fistulas providing a sphincter-sparing minimally invasive procedure.
2005
significant market introduction
Vivostat® PRF
Bringing Vivostat® PRF to the market was a major milestone for the company. Introducing the worlds first autologous platelet enriched fibrin matrix was quite an accomplishment the platform for future developments.
2001
commercialization
Vivostat® Fibrin
With the launch of Vivostat® Fibrin the company went from development into commercialization of the worlds first autologous fibrin sealant prepared on-site by health care professionals.
Vivostat® Co-Delivery
The revolutionary system makes it possible to co-apply e.g. stem cells or antibiotics with the Vivostat® product.
Vivostat® System
Using the Vivostat® System, you can prepare autologous platelets enriched fibrin with multiple growth factors embedded in a matrix.
